Clinical Trial Results: Safety and Efficacy of FVIIa to Prevent Excessive Bleeding in Hemophilia Patients With Inhibitors Undergoing Major Surgery [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the safety and efficacy of FVIIa to prevent excessive bleeding in hemophilia patients with inhibitors undergoing major surgery; study t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Snippet

Sponsor: Laboratoire français de Fractionnement et de Biotechnologies | Conditions: Hemophilia | Phase 3 | Status: TERMINATED | Results posted: 2026-07-31